|
KR102091464B1
|
|
Composition for anti-inflammation
|
|
KR101871166B1
|
|
Novel compound and composition for prevention, improvement or treatment of fibrosis or non-alcoholic steatohepatitis comprising the same
|
|
KR20180093396A
|
|
Mesenchymal stem cell line useful for developing fibrosis therapeutic agent
|
|
KR20150124382A
|
|
Pharmaceutical compositions for inhibiting the osteoclast differentiation comprising eupatilin
|
|
KR20150111830A
|
|
The PIRO as a new biomarker for osteoclast fusion
|
|
KR101564170B1
|
|
Pharmaceutical compositions for inhibiting the osteoclast differentiation comprising eupatilin
|
|
KR101522729B1
|
|
The PIRO as a new biomarker for osteoclast fusion
|
|
KR101433794B1
|
|
Composition comprising inhibitors of Progranulin for the prevention or treatment of osteoporosis
|
